A detailed history of Prudential PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Prudential PLC holds 36,773 shares of ABT stock, worth $4.33 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,773
Previous 26,844 36.99%
Holding current value
$4.33 Million
Previous $2.79 Million 50.3%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $993,595 - $1.17 Million
9,929 Added 36.99%
36,773 $4.19 Million
Q2 2024

Aug 06, 2024

BUY
$100.73 - $112.44 $285,065 - $318,205
2,830 Added 11.78%
26,844 $2.79 Million
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $4.07 Million - $4.49 Million
-37,143 Reduced 60.73%
24,014 $2.73 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $2.44 Million - $2.99 Million
-27,102 Reduced 30.71%
61,157 $6.73 Million
Q3 2023

Nov 09, 2023

SELL
$95.53 - $114.62 $7.63 Million - $9.16 Million
-79,881 Reduced 47.51%
88,259 $8.55 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $3.47 Million - $3.87 Million
-34,469 Reduced 17.01%
168,140 $18.3 Million
Q1 2023

May 12, 2023

BUY
$96.86 - $114.01 $6.41 Million - $7.55 Million
66,221 Added 48.55%
202,609 $20.5 Million
Q4 2022

Feb 08, 2023

BUY
$95.06 - $111.52 $2.17 Million - $2.55 Million
22,858 Added 20.13%
136,388 $15 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $3.66 Million - $4.24 Million
37,832 Added 49.98%
113,530 $11 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $137,692 - $166,426
1,349 Added 1.81%
75,698 $8.23 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $4.16 Million - $5.07 Million
36,480 Added 96.33%
74,349 $8.8 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $152,384 - $186,585
1,319 Added 3.61%
37,869 $5.33 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $28.4 Million - $31.4 Million
-243,523 Reduced 86.95%
36,550 $4.32 Million
Q2 2021

Aug 13, 2021

SELL
$105.79 - $124.53 $59.1 Million - $69.6 Million
-558,838 Reduced 66.61%
280,073 $32.5 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $22.4 Million - $26.4 Million
-206,041 Reduced 19.72%
838,911 $101 Million
Q4 2020

Feb 08, 2021

SELL
$105.0 - $114.42 $31.5 Million - $34.3 Million
-299,864 Reduced 22.3%
1,044,952 $114 Million
Q3 2020

Oct 30, 2020

BUY
$91.64 - $111.29 $5.98 Million - $7.27 Million
65,285 Added 5.1%
1,344,816 $146 Million
Q2 2020

Jul 31, 2020

SELL
$76.57 - $98.0 $12.9 Million - $16.6 Million
-169,087 Reduced 11.67%
1,279,531 $117 Million
Q1 2020

May 01, 2020

SELL
$62.82 - $91.86 $49.6 Million - $72.5 Million
-789,264 Reduced 35.27%
1,448,618 $114 Million
Q4 2019

Feb 13, 2020

SELL
$78.51 - $87.4 $1.72 Million - $1.92 Million
-21,961 Reduced 0.97%
2,237,882 $194 Million
Q3 2019

Nov 13, 2019

SELL
$81.84 - $88.74 $1.86 Million - $2.02 Million
-22,769 Reduced 1.0%
2,259,843 $189 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $26.4 Million - $30.8 Million
362,297 Added 18.87%
2,282,612 $192 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $38 Million - $46 Million
574,309 Added 42.67%
1,920,315 $154 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $8.85 Million - $10 Million
-135,058 Reduced 9.12%
1,346,006 $97.4 Million
Q3 2018

Nov 14, 2018

SELL
$60.81 - $73.36 $13 Million - $15.6 Million
-213,130 Reduced 12.58%
1,481,064 $109 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $800,223 - $883,206
-13,900 Reduced 0.81%
1,694,194 $103 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $5.11 Million - $5.78 Million
-90,891 Reduced 5.05%
1,708,094 $102 Million
Q4 2017

Feb 14, 2018

SELL
$53.68 - $57.47 $5.56 Million - $5.95 Million
-103,599 Reduced 5.45%
1,798,985 $103 Million
Q3 2017

Nov 14, 2017

SELL
$48.06 - $53.64 $1.36 Million - $1.52 Million
-28,326 Reduced 1.47%
1,902,584 $102 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,930,910
1,930,910 $93.9 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.